UBS lowered the firm’s price target on Oracle (ORCL) to $280 from $325. Oracle’s 41% drop from mid-September highs reflects investor concerns about its outlook and OpenAI’s impact on related stocks, the analyst tells investors in a research note. Despite this, UBS reaffirms its Buy rating given pending revenue growth, the ramp of Abilene data center capacity, potential reversal of cautious OpenAI sentiment in 1H26, and largely embedded credit/financing risks.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle price target lowered to $195 from $250 at RBC Capital
- Why Inflation Could Disrupt the AI Stock Rally in 2026
- Here’s What Wall Street Expects from Oracle Stock (ORCL) in 2026
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 4
- Eli Lilly, Oracle, Home Depot, Canopy, Rocket Lab Insider Shake-Up